In the published article the following incorrect statement appeared in the Patients and methods section: Group 1 (n = 75); was given on demand lidocaine 5% spray for 8 weeks (One to two applications (1-2 ml) of lidocaine 5% sprays; contain 5-10 mg of lidocaine, in a metered-dose aerosol-delivery system) (Lidocaine topical aerosol U.S.P. 38, The Arab Drug Co, Cairo, Egypt). Group 2 (n = 75); was given placebo in the form on demand alcohol spray for 8 weeks (One to two applications (1-2 ml) of alcohol 40% sprays).
In the published article the following incorrect statement appeared in the Patients and methods section: Group 1 (n = 75); was given on demand lidocaine 5% spray for 8 weeks (One to two applications (1-2 ml) of lidocaine 5% sprays; contain 5-10 mg of lidocaine, in a metered-dose aerosol-delivery system) (Lidocaine topical aerosol U.S.P. 38, The Arab Drug Co, Cairo, Egypt). Group 2 (n = 75); was given placebo in the form on demand alcohol spray for 8 weeks (One to two applications (1-2 ml) of alcohol 40% sprays).
The statement should read as follows: Group 1 (n = 75); was given on demand lidocaine 5% spray for 8 weeks (One to two applications (0.1-0.2 ml) of lidocaine 5% sprays; contain 5-10 mg of lidocaine, in a metered-dose aerosol-delivery system) (Lidocaine topical aerosol U.S.P. 38, The Arab Drug Co, Cairo, Egypt). Group 2 (n = 75); was given placebo in the form on demand alcohol spray for 8 weeks (One to two applications (0.1-0.2 ml) of alcohol 40% sprays). This has been corrected in both the PDF and HTML versions of the Article.
